Showing 34,848 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Epidemiology

Polish NGO decries lack of sex education as HIV cases soar

Editor's pick
Medical Xpress
4 December 2023
Discrimination & the law

Tennessee’s penalties for HIV-positive people are discriminatory, Justice Department says

Editor's pick
NBC News
4 December 2023
Epidemiology

On World AIDS Day, rising HIV rates in Israel

Editor's pick
The Jerusalem Post
4 December 2023
Activism & civil society

Ulanda Mtamba: One of BBC’s most influential 100 women

Editor's pick
The Nation Online
4 December 2023
Antibody-based prevention

Oral tenofovir/FTC increases clearance of bNAb VRC01: implications for future research

Editor's pick
i-Base
4 December 2023
Ageing & HIV

CD4:CD8 ratio recovery reduces with higher age when starting ART

Editor's pick
i-Base
4 December 2023
Improving HIV care

Integrating HIV and NCD care is critical but not straight-forward, clinicians say

Editor's pick
Spotlight
4 December 2023
HIV in the arts & media

Madonna Lived to Tell

Editor's pick
The New York Times
4 December 2023
Discrimination & the law

UK: Hospital staff failed man living with HIV by unnecessarily delaying surgery

Editor's pick
Parliamentary and Health Service Ombudsman
4 December 2023
Epidemiology

England: Decline in HIV transmission but progress slow in women

Editor's pick
UK Health Security Agency
4 December 2023
PrEP programmes & uptake

Black Americans still struggle to access PrEP, a medication that could lower HIV rates in the community

Editor's pick
CNN
4 December 2023
Menopause

Menopause May Affect Atherosclerosis Risk Differently in People With HIV, Reports U.S. Study

Editor's pick
TheBodyPro
4 December 2023
Injectable & long-acting PrEP

Follow-Up Study Affirms Efficacy of Injectable Cabotegravir for PrEP, Though Questions Remain on Hypertension, Resistance

Editor's pick
TheBodyPro
4 December 2023
Epidemiology

Despite progress, adolescent girls continue to bear the brunt of the HIV epidemic with 98,000 new infections in 2022

Editor's pick
UNICEF
4 December 2023
Harm reduction

‘Drug use is a health problem’: inside one of the world’s oldest legal consumption rooms

Editor's pick
The Guardian
4 December 2023
Activism & civil society

From 'Condom Man' to Full-Service HIV Clinic: How One Team in Uganda Serves Key Populations

Editor's pick
Global Health Now
1 December 2023
News about aidsmap

New data published on HIV Lens for World AIDS Day

News
1 December 2023
Treatment guidelines

EACS 2023: European guidelines fully revised (October 2023)

Editor's pick
i-Base
1 December 2023
Epidemiology

South Africans are living longer, mostly thanks to HIV treatment

Editor's pick
Ground Up
1 December 2023
People & personal stories

'Will someone still love me?': What it's like sharing a HIV status in 2023

Editor's pick
ABC News
1 December 2023
HIV treatment for children & young people

Young children have highest mortality rate among people treated for HIV

Editor's pick
Healio
1 December 2023
Combatting stigma

Ryan White, a Poster Child for AIDS Obscured as Much About the Crisis as He Revealed

Editor's pick
TIME
1 December 2023
PrEP programmes & uptake

Study identifies barriers that limit young men at HIV risk from taking preventative drug

Editor's pick
EurekAlert!
1 December 2023
Injectable & long-acting PrEP

Long-Acting PrEP in Europe's Fight Against HIV

Editor's pick
Medscape (requires free registration)
1 December 2023